Literature DB >> 25573887

Loperamide therapy for voluminous diarrhea in Ebola virus disease.

Daniel S Chertow1, Timothy M Uyeki2, Herbert L DuPont3.   

Abstract

Entities:  

Keywords:  Ebola; diarrhea; gastrointestinal losses; hypovolemia; loperamide

Mesh：

Substances：

Year:  2015        PMID： 25573887      PMCID： PMC4366607          DOI： 10.1093/infdis/jiv001

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  Clinical care of two patients with Ebola virus disease in the United States.

Authors:  G Marshall Lyon; Aneesh K Mehta; Jay B Varkey; Kent Brantly; Lance Plyler; Anita K McElroy; Colleen S Kraft; Jonathan S Towner; Christina Spiropoulou; Ute Ströher; Timothy M Uyeki; Bruce S Ribner
Journal:  N Engl J Med       Date:  2014-11-12       Impact factor: 91.245

Review 2.  Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis.

Authors:  Hoonmo L Koo; Diana C Koo; Daniel M Musher; Herbert L DuPont
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

3.  Ebola virus disease in West Africa--clinical manifestations and management.

Authors:  Daniel S Chertow; Christian Kleine; Jeffrey K Edwards; Roberto Scaini; Ruggero Giuliani; Armand Sprecher
Journal:  N Engl J Med       Date:  2014-11-05       Impact factor: 91.245

Review 4.  Cholera.

Authors:  Jason B Harris; Regina C LaRocque; Firdausi Qadri; Edward T Ryan; Stephen B Calderwood
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

5.  Adverse effect of lomotil therapy in shigellosis.

Authors:  H L DuPont; R B Hornick
Journal:  JAMA       Date:  1973-12-24       Impact factor: 56.272

Review 6.  Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.

Authors:  Roosecelis Brasil Martines; Dianna L Ng; Patricia W Greer; Pierre E Rollin; Sherif R Zaki
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

Review 7.  Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis.

Authors:  Mark S Riddle; Sarah Arnold; David R Tribble
Journal:  Clin Infect Dis       Date:  2008-10-15       Impact factor: 9.079

8.  Ciprofloxacin and loperamide in the treatment of bacillary dysentery.

Authors:  G S Murphy; L Bodhidatta; P Echeverria; S Tansuphaswadikul; C W Hoge; S Imlarp; K Tamura
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

Review 9.  Loperamide: a pharmacological review.

Authors:  Daniel E Baker
Journal:  Rev Gastroenterol Disord       Date:  2007

10.  Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis.

Authors:  Su-Ting T Li; David C Grossman; Peter Cummings
Journal:  PLoS Med       Date:  2007-03-27       Impact factor: 11.069
  10 in total
  9 in total

Review 1.  Critical Care Medicine and Infectious Diseases: An Emerging Combined Subspecialty in the United States.

Authors:  Sameer S Kadri; Chanu Rhee; Gregory S Fortna; Naomi P O'Grady
Journal:  Clin Infect Dis       Date:  2015-05-05       Impact factor: 9.079

2.  Peripheral Neuronopathy Associated With Ebola Virus Infection in Rhesus Macaques: A Possible Cause of Neurological Signs and Symptoms in Human Ebola Patients.

Authors:  David X Liu; Donna L Perry; Timothy K Cooper; Louis M Huzella; Randy J Hart; Amanda M W Hischak; John G Bernbaum; Lisa E Hensley; Richard S Bennett
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

Review 3.  Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.

Authors:  Julie Dyall; Robin Gross; Jason Kindrachuk; Reed F Johnson; Gene G Olinger; Lisa E Hensley; Matthew B Frieman; Peter B Jahrling
Journal:  Drugs       Date:  2017-12       Impact factor: 9.546

Review 4.  Clinical Management of Patients with Ebola Virus Disease in High-Resource Settings.

Authors:  G Marshall Lyon; Aneesh K Mehta; Bruce S Ribner
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 5.  Ebola virus disease.

Authors:  Shevin T Jacob; Ian Crozier; William A Fischer; Angela Hewlett; Colleen S Kraft; Marc-Antoine de La Vega; Moses J Soka; Victoria Wahl; Anthony Griffiths; Laura Bollinger; Jens H Kuhn
Journal:  Nat Rev Dis Primers       Date:  2020-02-20       Impact factor: 52.329

6.  Loperamide Inhibits Replication of Severe Fever with Thrombocytopenia Syndrome Virus.

Authors:  Shuzo Urata; Jiro Yasuda; Masaharu Iwasaki
Journal:  Viruses       Date:  2021-05-10       Impact factor: 5.048

7.  The Individualised versus the Public Health Approach to Treating Ebola.

Authors:  Tom H Boyles
Journal:  PLoS Med       Date:  2015-07-28       Impact factor: 11.069

Review 8.  Ebola virus disease and critical illness.

Authors:  Aleksandra Leligdowicz; William A Fischer; Timothy M Uyeki; Thomas E Fletcher; Neill K J Adhikari; Gina Portella; Francois Lamontagne; Christophe Clement; Shevin T Jacob; Lewis Rubinson; Abel Vanderschuren; Jan Hajek; Srinivas Murthy; Mauricio Ferri; Ian Crozier; Elhadj Ibrahima; Marie-Claire Lamah; John S Schieffelin; David Brett-Major; Daniel G Bausch; Nikki Shindo; Adrienne K Chan; Tim O'Dempsey; Sharmistha Mishra; Michael Jacobs; Stuart Dickson; G Marshall Lyon; Robert A Fowler
Journal:  Crit Care       Date:  2016-07-29       Impact factor: 9.097

9.  Differences in the Comparative Stability of Ebola Virus Makona-C05 and Yambuku-Mayinga in Blood.

Authors:  Michael Schuit; David M Miller; Mary S Reddick-Elick; Carly B Wlazlowski; Claire Marie Filone; Artemas Herzog; Leremy A Colf; Victoria Wahl-Jensen; Michael Hevey; James W Noah
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.